Two Arizona leaders in scientific collaboration partner to advance global TB research May 1, 2017 Two Arizona leaders in scientific collaboration partner to advance global TB research TUCSON and FLAGSTA
Critical Path Institute and TGen Forge Partnership to Advance TB Research May 1, 2017 Critical Path Institute and TGen Forge Partnership to Advance TB Research TUCSON and FLAGSTAFF, May 1,
January 3, 2017 Removing the Bottleneck in Whole Genome Sequencing of Mycobacterium Tuberculosis for Rapid Drug Resistance Analysis: A Call to Action
January 10, 2015 A Collaborative Approach for “ReSeq-Ing” Mycobacterium Tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers
January 4, 2015 Integration of Published Information into a Resistance-Associated Mutation Database for Mycobacterium Tuberculosis
C-Path Looks to Speed Gene Based Therapies Your doctor may soon – perhaps in a year – be able to order up a test to map out your entire genome, or genetic bluepr
Could Genetics Improve Warfarin Dosing? In a large-scale study and an upcoming clinical trial, scientists supported by the National Institutes of Health address one of th
US News & World Report – Genetic Tests Predict Response to Warfarin Variations of a gene that determines a person’s sensitivity to warfarin are important in determining the initial doses of th
